Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Livitol-70 is a herbal medicine developed as an antioxidant supplement intended to improve hepatic function in patients with alcoholic liver disease who do not have cirrhosis. It is formulated from three whole herbs and their extracts, which are reported to possess antioxidant, hepatoprotective (liver-protecting), and reno-protective (kidney-protecting) properties. The product is being studied for its efficacy in improving liver function among individuals with alcohol-induced liver damage. Its mechanism of action centers on reducing oxidative stress and supporting hepatic health through the combined effects of its herbal components[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Livitol-70.